KHTRF - Knight Therapeutics Inc. (KHTRF) CEO Jonathan Ross Goodman on Q4 2020 Results - Earnings Call Transcript

Knight Therapeutics Inc. (KHTRF) Q4 2020 Results Earnings Conference Call March 25, 2021, 08:30 AM ET Company Participants Jonathan Ross Goodman - Chief Executive Officer Samira Sakhia - President & Chief Operating Officer Amal Khouri - Chief Business Officer Arvind Utchanah - Chief Financial Officer1 Jeff Martens - VP, Commercial Conference Call Participants Andre Uddin - Mackie Capital David Martin - Bloom Burton Justin Keywood - Stifel Endri Leno - National Bank Douglas Miehm - ARV Capital. David Novak - Raymond James David Martin - New Bern Rob Curry - Louisbourg Investment Tania Gonsalves - Canaccord Presentation Operator Good morning, ladies and gentlemen. My name is Gershan [ph], and I will be your operator today. Welcome to the Knight Therapeutics Inc. 2020 Fourth Quarter Financial Results Conference Call. Before turning the call over to Jonathan Ross Goodman, CEO of Knight, listeners are reminded that portion of today's discussion may, by

For further details see:

Knight Therapeutics Inc. (KHTRF) CEO Jonathan Ross Goodman on Q4 2020 Results - Earnings Call Transcript